A Study of Canagliflozin and Metformin Immediate Release (150 mg/500 mg) FDC Tablets in Healthy Volunteers
Clinical trial NCT01508182 · COMPLETED
Trial details
- NCT number
- NCT01508182
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2012-03-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.